BBIO
BridgeBio Pharma·NASDAQ
--
--(--)
--
--(--)
2.43 / 10
Underperform
Technical composite 2.43/10 (Underperform). No bullish signals; both Long Lower Shadow and MACD Golden Cross register low scores (~2.4) with weak win rates. Market shows bearish bias and limited recent activity, indicating heightened downside risk.
Analysis Checks(0/2)
Long Lower Shadow
Score2.47/10
Win Rate42.86%
Hist. Signals14
Avg Return0.01%
Score2.47/10
Win Rate42.86%
Hist. Signals14
Avg Return0.01%
MACD Golden Cross
Score2.39/10
Win Rate40.00%
Hist. Signals10
Avg Return0.44%
Score2.39/10
Win Rate40.00%
Hist. Signals10
Avg Return0.44%
Long Lower Shadow
Score2.47/10
Win Rate42.86%
Hist. Signals14
Avg Return0.01%
Score2.47/10
Win Rate42.86%
Hist. Signals14
Avg Return0.01%
MACD Golden Cross
Score2.39/10
Win Rate40.00%
Hist. Signals10
Avg Return0.44%
Score2.39/10
Win Rate40.00%
Hist. Signals10
Avg Return0.44%
What is the current technical signals for BBIO?
- BBIO presents a Underperform setup with a Technical Score of 2.43/10. Key technical indicators highlight an RSI of 58.05 and a MACD of 0.99, with the trend anchored by the 50-Day SMA at 71.68.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
